Meyers is an experienced marketer with 20 years ofexperience in printing and graphic arts. “I believe the Equitrac green, cost controlvalue proposition really resonates in the current business climate, and Iam excited to help contribute to Equitrac’s growth.”Kimberly Meyers joins Equitrac as its Senior Director of Marketingresponsible for its worldwide marketing programs with a keen focus onchannel marketing. Hartnett holds an MBA fromRochester Institute of Technology in New York, where he was also electedto the Beta Gamma Sigma Honor Society and a BBA in Finance from St.Bonaventure University in New York.”I have always been impressed with the people and solutions offered atEquitrac,” said Hartnett. Prior to this position, Hartnett also managed multiple OEMchannel sales teams at EFI and worked at Xerox for 13 years in a varietyof sales and business development positions. Prior to joining Equitrac, heserved as the Director of Sales for digital print solutions leader EFI,with responsibility for the company’s largest channel sales team, XeroxNorth America. Hartnett brings over 20years of successful national and global sales and business developmentexperience in both partner and direct sales.

As a result, the companyrequired additional leadership to expand support for customers and channelpartners.As Vice President of North American Partner Sales, Hartnett is responsiblefor managing and further developing Equitrac’s relationships with channelpartners including the industry’s major print equipment manufacturersCanon, HP, Konica Minolta, Oce, Ricoh, Sharp, Toshiba and Xerox and theirdistribution network of resellers and dealers. PLANTATION, FL, Jun 22 (MARKET WIRE) — Equitrac Corporation, the world’s leading print and cost managementsolutions provider, today announced the enhancement of its managementteam with additional leadership — Joe Hartnett, Vice President of NorthAmerican Partner Sales and Kimberly Meyers, Senior Director of Marketing.Despite the challenging economy, Equitrac continues to expand and grow itsbusiness, distribution and customer reach. at company, brand, or product names contained in this document may betrademarks or registered trademarks of their respective holders.For more information, contact:Decision Resources Decision Resources, Inc.Christopher ComfortElizabeth Marshall781-296-2597 SOURCEDecision ResourcesChristopher Comfort of Decision Resources, +1-781-296-2597,; or Elizabeth Marshall of Decision Resources, Inc.,+1-781-296-2563, . Clients rely on this analysis and data to make informeddecisions Please visit Decision Resources, Inc. is a cohesive portfolio of companies that offersbest-in-class, high-value information and insights on important sectors of thehealthcare industry.

“Compounds from these new classes willinitially be added to the backbone of currently used agents, forming triple orquadruple treatment regimens that are expected to be more efficacious than thecurrent standard of care.”About Decision ResourcesDecision Resources () is a world leader in marketresearch publications, advisory services and consulting designed to helpclients shape strategy, allocate resources and master their chosen markets.Decision Resources is a Decision Resources, Inc company About Decision Resources, Inc.Decision Resources, Inc. Such factors include, among others,Dussault’s ability to design and manufacture its products, the ability ofthe products to gain market acceptance, and the difficulties faced by anearly stage retail fashion company in the competitive retail fashionindustry. Such forward-looking statements include “tentatively scheduledto open in late July 2009.”These forward-looking statements are made as of the date of this newsrelease, and the Company assumes no obligation to update theforward-looking statements, or to update the reasons why actual resultscould differ from those projected in the forward-looking statements.Although the Company believes that the beliefs, plans, expectations andintentions contained in this press release are reasonable, there can be noassurance that such beliefs, plans, expectations or intentions will proveto be accurate. Several agents in late-stage development — most notablyprotease inhibitors such as Vertex/Johnson & Johnson/Mitsubishi Tanabe’stelaprevir and Schering-Plough’s boceprevir as well as polymerase inhibitorssuch as Roche/Pharmasset’s R-7128 and Pfizer’s filibuvir — will drive marketgrowth.”The standard of care will change significantly with the introduction of newclasses of hepatitis C virus-specific antiviral agents, such as proteaseinhibitors and polymerase inhibitors,” said Decision Resources AnalystAlexandra Makarova, M.D., Ph.D. Roche and Schering-Plough will continue to be prominent playersand a number of other companies — including Johnson & Johnson and Pfizer –will also carve out a share in the market.The report also finds that the competitive hepatitis C virus pipeline ischaracterized by its significant commercial potential which is well-recognizedby drug developers. However, market growththereafter will decrease to $3.4 billion in 2018 owing to a decline in theprevalence of the disease and the high efficacy of new treatment regimens.The new Pharmacor report entitled Hepatitis C Virus finds that, through 2013,robust market growth will be driven by the launches of novel hepatitis Cvirus-specific agents and an increase in the size of the drug-treatedpopulation.

Hepatitis C Virus Market Will Expand Dramatically From $2 Billion in 2008 toNearly $7.7 Billion in 2013Roche and Schering-Plough Will Continue to be Prominent Players in the Market,According to a New Report from Decision ResourcesWALTHAM, Mass., June 22 /PRNewswire/ — Decision Resources, one of the world’sleading research and advisory firms for pharmaceutical and healthcare issues,finds that the hepatitis C virus drug market will expand dramatically from $2billion in 2008 to nearly $7.7 billion in 2013 in the United States, France,Germany, Italy, Spain, the United Kingdom and Japan. Investors should consult all of the information set forthherein and should also refer to the risk factors disclosure outlined inthe Company’s recent current reports on Form 8-K, our annual report onForm 10-KSB, our quarterly reports on Form 10-Q, and other periodic andcurrent reports filed from time to time with the Securities and ExchangeCommission.For additional information contact:Dussault Apparel(TM) Media RelationsTina BairdVP Communications310-424-5244 (US)604-628-4946 (Canada)Copyright 2009, Market Wire, All rights reserved.-0-. Statements in thispress release that are not purely historical are forward-lookingstatements and include any statements regarding beliefs, plans,expectations or intentions regarding the future.Actual results could differ from those projected in any forward-lookingstatements due to numerous factors. In keeping withthe Company’s green-friendly philosophy, the design will strive toutilize as much reclaimed materials as possible.Forward-Looking StatementsThis news release contains “forward-looking statements,” as that term isdefined in Section 27A of the United States Securities Act of 1933 andSection 21E of the Securities Exchange Act of 1934. VANCOUVER, BC, Jun 22 (MARKET WIRE) — Dussault Apparel Inc.(“The Company”) (OTCBB: DUSS) announced today thatit will open a corporate showroom in Vancouver, B.C tentativelyscheduled to open in late July 2009.